NIPH Clinical Trials Search

The effect of dexmedetomidine in the acute decompensated heart failure

Basic Information

Recruitment status	Pending
Health condition(s) or Problem(s) studied	heart failure
Date of first enrollment	2013/11/20
Target sample size	20
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	In the acute heart failure, Carperitide administered in addition to the conventional diuretic and cardiotonic medicine Instead of Carperitide, Dexmedetomidine 0.4 ug/kg/h administered

Outcome(s)

Primary Outcome	Urine output,Catecholamine fraction(dopamine,adrenalin,noradrenalin),Renin activaion,aldosterone,ADH before and after the use od Dexmedetomidine in ADHF Survival rate of one,three,five years
Secondary Outcome	Creatinine,Heart rate,Blood pressure,Interleukin6,TNF-6,blood serum and urine Na K Cl,blood and urine osmotic pressure

Key inclusion & exclusion criteria

Age minimum	30years-old
Age maximum	90years-old
Gender	Male and Female
Include criteria
Exclude criteria	Under systoric blood pressure 80 mmHg